Mayo Clinic in Jacksonville
Jacksonville, Florida, 32224, United States
NCT Number: NCT00896792
RATIONALE: Gathering information about patients with terminal metastatic cancer may help doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not yet known whether a nurse practitioner program helps increase patients' length of stay in hospice.
PURPOSE: This randomized research study is evaluating a nurse practitioner hospice program for patients with terminal metastatic cancer and their families or caregivers.
Looking for future studies?
Notify Me18 year–120 year
All sexes
Interventional
Early Phase 1
Jacksonville, Florida, 32224, United States
OBJECTIVES:
Primary
Secondary
OUTLINE: Patients are randomized to 1 of 2 arms.
Patients participate in this study for a duration of 21 days while in hospice care. At the completion of the study, patients in both arms complete questionnaires about pain management, social, emotional, and spiritual and mental well-being. Patients' families or caregivers complete the Caregiver Questionnaire and the Hospice Family Satisfaction Survey 3 weeks after patient's death.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Mayo Clinic
Other
The Pilot Palliative ARNP (Advanced Registered Nurse Practitioner) Liaison Program (The PAL Program): Improving Communication Between Patients, Oncologists, and Hospice, Promoting Timely Hospice Referrals and Bringing Education and Research Efforts to Hospice and Palliative Care
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02116530
Hematologic Diseases, Hematologic Neoplasms
Anchorage, Alaska, United States
View Trial DetailsNCT01866969
Hematologic Diseases, Hematologic Neoplasms
Duarte, California, United States
View Trial DetailsNCT00769951
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsNCT01982682
Hematologic Diseases, Hematologic Neoplasms
Philadelphia, Pennsylvania, United States
View Trial Details